What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001873893
Total reported value
$419.5M
$419.5M
12 檔
55.8%
As reported in its official Q3 2025 Form 13F filing, 325 Capital LLC's tracked investment portfolio stood at $419.5M with 12 total positions.
During Q3 2025, 325 Capital LLC performed routine portfolio adjustments (1 new buys, 1 additions, 2 trims, and 0 full exits), keeping overall allocation balanced.
In terms of portfolio concentration, the top 5 core holdings (including ATRO, APEI, BLBD) accounted for 55.8% of total reported equity market value during Q3 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ATRO | Astronics CORP | Stock-Other | 18.86% | — | — | |
| 2 | APEI | American Public Education | Stock-Other | 18.33% | -9.38% | — | |
| 3 | BLBD | Blue Bird CORP | Stock-Other | 13.52% | -0.68% | — | |
| 4 | ASTH | Astrana Health Inc | Stock-Other | 10.29% | +1.42% | +34.62% | |
| 5 | MPAA | Motorcar Parts Of America In | Stock-Other | 10.15% | -0.76% | — | |
| 6 | SPIR | Spire Global Inc | Stock-Other | 6.26% | +4.57% | — | |
| 7 | AIOT | Powerfleet Inc | Stock-Other | 5.81% | +0.51% | — | |
| 8 | LFCR | Lifecore Biomedical Inc | Stock-Other | 4.84% | +0.69% | — | |
| 9 | MGNI | Magnite Inc | Stock-Other | 4.30% | +6.76% | — | |
| 10 | BTMD | Biote CORP -a | Stock-Other | 4.15% | -0.19% | — | |
| 11 | ✓ | Multisensor Ai Holdings Inc C | Stock-Other | 1.84% | -2.23% | EXIT | |
| 12 | TACT | Transact Technologies Inc | Stock-Other | 1.67% | +0.20% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BLBD | Blue Bird CORP | +3.2% | — | Unchanged |
| 2 | MPAA | Motorcar Parts Of America In | +2.2% | — | Unchanged |
| 3 | ATRO | Astronics CORP | +1.9% | — | Trim |
| 4 | TACT | Transact Technologies Inc | +0.1% | — | Unchanged |
| 5 | SPIR | Spire Global Inc | 0% | — | Unchanged |
| 6 | ASTH | Astrana Health Inc | -1.1% | +34.62% | Add |
| 7 | LFCR | Lifecore Biomedical Inc | -1.5% | — | Unchanged |
| 8 | ✓ | Multisensor Ai Holdings Inc C | -1.8% | — | Unchanged |
| 9 | BTMD | Biote CORP -a | -2.1% | — | Unchanged |
| 10 | AIOT | Powerfleet Inc | -2.5% | — | Unchanged |
| 11 | APEI | American Public Education | -2.7% | — | Trim |
| 12 | MGNI | Magnite Inc | — | NEW | New buy |
According to official SEC Form 13F filings, 325 Capital LLC reported a total U.S. public equity portfolio value of $419.5M across 12 disclosed positions in Q3 2025.
During Q3 2025, 325 Capital LLC's top holdings by market value included ATRO (18.9%)、APEI (18.3%)、BLBD (13.5%). The largest single position, ATRO, represented 18.9% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
MGNI
市值: $14.2M
Top Position Liquidated / Trimmed
APEI
前期市值: $50.7M
In Q3 2025, 325 Capital LLC made 4 total portfolio adjustments, initiating 1 new buys, adding to 1 positions, trimming 2 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.